RODOLFO TREJO: Open Payments
NPI 1750335584 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,408 in 195 payments from 34 companies in 2025. Trend: 2023 $5,193 · 2024 $6,132 · 2025 $6,408
Food & beverage: $6,408
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $1,391 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $694 |
| ABBVIE INC. | 19 | $597 |
| Otsuka America Pharmaceutical, Inc. | 8 | $298 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $293 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $284 |
| Phathom Pharmaceuticals, Inc. | 2 | $230 |
| Abbott Laboratories | 9 | $201 |
| Astellas Pharma US Inc | 7 | $192 |
| Exact Sciences Corporation | 9 | $189 |
Products named: AIRSUPRA, CAPLYTA, REXULTI, XIFAXAN, Kerendia, BREZTRI, VOQUEZNA, LINZESS.
Industry payments across FL — which companies pay providers there.
